We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
11 hedge funds and large institutions have $10.4M invested in Zealand Pharma A/S American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
10% more funds holding
Funds holding: 10 → 11 (+1)
17% less capital invested
Capital invested by funds: $12.5M → $10.4M (-$2.1M)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$6.43M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$3.66K |
| 3 |
Jane Street
New York
|
+$3.36K |
| 4 |
Morgan Stanley
New York
|
+$2.56K |